The Effects of Probiotics Combined With Glutamine in the Prevention and Treatment of Radiation Proctitis
Radiation Proctitis, Probiotics, Glutamine
About this trial
This is an interventional prevention trial for Radiation Proctitis
Eligibility Criteria
Inclusion Criteria:
- locally advanced rectal adenocarcinoma diagnosed by histopathology; clinical stage T3/4 or N+(AJCC,8th), no metastasis; and planned to receive preoperative neoadjuvant concurrent chemoradiotherapy.
- without other malignant tumors;
- Those without serious heart, liver, kidney and other diseases;
- ECOG score: 0-1.
Exclusion Criteria:
- Complicated with ulcerative colitis or Crohn's disease;
- Complicated with severe organ insufficiency, severe diabetes, and heart disease;
- Pregnant and lactating women;
- Abnormal bowel movements with systemic and metabolic diseases;
- The patient has a history of using systemic antibiotics and intestinal active bacteria in the past 1 month.
Sites / Locations
- West China HospitalRecruiting
- Xin WangRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
combination therapy group
control group
From the first day of chemoradiotherapy, live combined Bifidobacterium and Lactobacillus tablets(2000mg each time, 3 times/day) combined with compound glutamine enteric-coated capsules (3 capsules each time, 3 times/day) until 1 month after the end of chemoradiotherapy.
After the start of chemoradiotherapy, the control group don't take the experimental drug orally . When patients have radiation proctitis of grade ≥2, they would be crossed over to the combined treatment group:live combined Bifidobacterium and Lactobacillus tablets(2000mg each time, 3 times/day) combined with compound glutamine enteric-coated capsules (3 capsules each time, 3 times/day) until 1 month after the end of chemoradiotherapy.